logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
MAP kinase-activated protein kinase 2 Inhibitors (IC50, Ki)
Structure
Compound Name
Standard Type
Standard Values (in nM)
StaurosporineIC5036.25 [1], 110.0 [2], 150.0 [3], 400.0 [4], 660.0 [5]
6-(4-Chlorophenyl)-N-[4-(4-methylpiperazin-1-yl)phenyl]quinolin-4-amineIC50600.0 [1]
6-(4-Chlorophenyl)-N-[4-(4-methylpiperazin-1-yl)phenyl]quinolin-4-amineKi96.0 [1], 310.0 [2], 320.0 [3], 480.0 [4]
2-[2-(2-Fluorophenyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-oneIC50126.0 [1], 560.0 [2], 4000.0 [3], 8900.0 [4]
5-(4-Chlorophenyl)-N-(4-piperazin-1-ylphenyl)-N-(pyridin-2-ylmethyl)furan-2-carboxamideIC50110.0 [1]

Rows per page:

1–5 of 100

References
This online resource may be cited as follows
MLA
"Quest Database™ MAP kinase-activated protein kinase 2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 5 Nov. 2025, https://www.aatbio.com/data-sets/map-kinase-activated-protein-kinase-2-inhibitors-ic50-ki.
APA
AAT Bioquest, Inc. (2025, November 5). Quest Database™ MAP kinase-activated protein kinase 2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/map-kinase-activated-protein-kinase-2-inhibitors-ic50-ki.
BibTeXEndNoteRefMan